Kris Johnson

Insider profile

Currently holds positions in Spectranetics Corp, Clearpoint Neuro Inc, AtriCure Inc and ViewRay Inc

Performance

Overall performance
1.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 5% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -97%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chairman of the Board Spectranetics Corp June 14, 2017 -
Director Clearpoint Neuro Inc Sept. 1, 2019 -
Independent Director AtriCure Inc March 21, 2017 -
Independent Director ViewRay Inc April 14, 2020 -
Independent Director Piper Sandler Companies Feb. 1, 2018 - Dec. 31, 2019
Lead Independent Director Piper Sandler Companies Jan. 1, 2012 - Feb. 1, 2018
Independent Director Spectranetics Corp May 31, 2012 - June 14, 2017
Independent Director Piper Sandler Companies Dec. 31, 2003 - Jan. 1, 2012
Kris Johnson's trades of AtriCure Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
397.68
Quantity 58,727
Value US$3,324,079
US ViewRay Inc (VRAY)
Transaction date
Sale
Price
174.00
Quantity 24,596 +30.4%
Value US$2,036,376
US ViewRay Inc (VRAY)
Transaction date
Proposed sale
Price
393.30
Quantity 89,669
Value US$2,563,101
US ViewRay Inc (VRAY)
Transaction date
Sale
Price
0.07
Quantity 79,622 -33.6%
Value US$5,653
US ViewRay Inc (VRAY)
Transaction date
Proposed sale
Price
0.07
Quantity 79,622
Value US$5,653
US ViewRay Inc (VRAY)
Transaction date
Purchase
Price
2.82
Quantity 40,000 +21.9%
Value US$112,704
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-06 2026-11-06
US AtriCure Inc (ATRC)
PrS Proposed sale
58,727
397.68
US$3,324,079 		58,727 397.68 US$3,324,079
2023-07-24 2023-07-21
US ViewRay Inc (VRAY)
S Sale
24,596 +30.4%
174.00
US$2,036,376 		24,596 +30.4% 174.00 US$2,036,376
2023-07-21 2023-07-21
US ViewRay Inc (VRAY)
PrS Proposed sale
89,669
393.30
US$2,563,101 		89,669 393.30 US$2,563,101
2023-07-20 2023-07-18
US ViewRay Inc (VRAY)
S Sale
79,622 -33.6%
0.07
US$5,653 		79,622 -33.6% 0.07 US$5,653
2023-07-18 2023-07-18
US ViewRay Inc (VRAY)
PrS Proposed sale
79,622
0.07
US$5,653 		79,622 0.07 US$5,653
2022-05-12 2022-05-12
US ViewRay Inc (VRAY)
B Purchase
40,000 +21.9%
2.82
US$112,704 		40,000 +21.9% 2.82 US$112,704